| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 655.69 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Descrição
Abstract in proceedings of the Fourth International Congress of CiiEM: Health, Well-Being and Ageing in the 21st Century, held at Egas Moniz’ University Campus in Monte de Caparica, Almada, from 3–5 June 2019.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Palavras-chave
HIV vif Docetaxel Breast cancer cells
Contexto Educativo
Citação
Pedro Cipriano, Susana Bandarra, João Gonçalves, Ana Clara Ribeiro & Isabel Barahona (2021) HIV Vif protein in docetaxel treatment of breast cancer cells, Annals of Medicine, 53:sup1, S94-S95, DOI: 10.1080/07853890.2021.1895585
Editora
Taylor and Francis